Inhibition of monoamine oxidase A increases recovery after experimental cardiac arrest

Interactive Cardiovascular and Thoracic Surgery

Volumn 21, Issue 4, 2015, Pages 441-449

  Vuohelainen, Vilma ^a   Hämäläinen, Mari ^a   Paavonen, Timo ^b   Karlsson, Sari ^c   Moilanen, Eeva ^a   Mennander, Ari ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FIMLAB LABORATORIES   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cardiac arrest; Monoamine oxidase A inhibition; Myocardial infarct

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CD68 ANTIGEN; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; MOCLOBEMIDE; PYRUVIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL COUNT; CELL MATURATION; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ENZYME INHIBITION; EXPERIMENTAL DISEASE; FISCHER 344 RAT; HEART ARREST; HEART BLOOD VESSEL; HEART INFARCTION; HEART MUSCLE METABOLISM; HEART PERFUSION; HEART TRANSPLANTATION; HETEROTOPIC TRANSPLANTATION; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MACROPHAGE; MYOCARDITIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE; ANIMAL; CARDIAC MUSCLE; COMPLICATION; CONVALESCENCE; CORONARY BLOOD VESSEL; DISEASE MODEL; DRUG EFFECTS; EVALUATION STUDY; HEART; LIGATION; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; SURGERY; TREATMENT OUTCOME;

ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HEART; HEART ARREST; HEART TRANSPLANTATION; LIGATION; MOCLOBEMIDE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, INBRED F344; REACTIVE OXYGEN SPECIES; RECOVERY OF FUNCTION; TRANSPLANTATION, HETEROTOPIC; TREATMENT OUTCOME;

EID: 84943559728     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivv175     Document Type: Conference Paper

References (25)

1. Guney MR, Ketenci B, Yapici F, Sokullu O, Firat MF, Uyarel H et al. Results of treatment methods in cardiac arrest following coronary artery bypass grafting. J Card Surg 2009;24:227-33.
2. Abbate A, Bussani R, Liuzzo G, Biondi-Zoccai GG, Barresi E, Mellone P et al. Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. Heart 2008;94:737-42.
3. Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L et al. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 2005;112:3297-305.
4. Hong H, Aksenov S, Guan X, Fallon JT, Waters D, Chen C. Remodeling of small intramyocardial coronary arteries distal to a severe epicardial coronary artery stenosis. Arterioscler Thromb Vasc Biol 2002;22:2059-65.
5. Sturza A, Leisegang MS, Babelova A, Schröder K, Benkhoff S, Loot AE et al. Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension 2013;62:140-6.
6. Coatrieux C, Sanson M, Negre-Salvayre A, Parini A, Hannun Y, Itohara S et al. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the shingolipid pathway. Free Radic Biol Med 2007;43:80-9.
7. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N et al. Oxidative stress-dependent spingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 2007; 100:41-9.
8. Bianchi P, Pimentel DR, Murphy MP, Colucci WS, Parini A. A new hyper-trophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J 2005;19:641-3.
9. Wang Z, Li H, Vuohelainen V, Tenhunen J, Hämäläinen M, Rinne T et al. Confined ischemia may improve remote myocardial outcome after rat cardiac arrest. Scand J Clin Lab Invest 2014;74:27-36.
10. Oriyanhan W, Tsuneyoshi H, Nishina T, Matsuoka S, Ikedo T, Komeda M. Determination of optimal duration of mechanical unloading for failing hearts to achieve bridge to recovery in a rat heterotopic transplantation model. J Heart Lung Transplant 2007;26:16-23.
11. Yang J, Chen L, Yang J, Ding J, Rong H, Dong W et al. High mobility group box-1 induces migration of vascular smooth muscle cells via TLR4-dependent PI3K/Akt pathway activation. Mol Biol Rep 2012;39:3361-7.
12. Kalinina N, Agrotis A, Antropova Y, DiVitto G, Kanellakis P, Kostolias G et al. Increased expression of the DNA-binding HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004;24:2320-5.
13. Anan M, Abe T, Matsuda T, Ishii K, Kamida T, Fujiki M et al. Induced angio-genesis under cerebral ischemia by cyclooxygenase 2 and hypoxia-indu-cible factor naked DNA in a rat indirect-bypass model. Neuroscience Lett 2006;409:118-23.
14. Yun N, Eum HA, Lee SM. Protective role of heme oxygenase-1 against liver damage caused by hepatic ischemia and reperfusion in rats. Antioxid Redox Signal 2010;13:1503-12.
15. -ΔΔCt method. Methods 2001;25: 402-8.
16. Day RM, Agyeman AS, Segel MJ, Chévere RD, Angelosanto JM, Suzuki YJ et al. Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol 2006;71:386-97.
17. Liu Y, Wei L, Laskin DL, Fanburg BL. Role of protein transamidation in serotonin-induced proliferation and migration of pulmonary artery smooth muscle cells. Am J Respir Cell Mol Biol 2011;44:548-55.
18. Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A et al. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J 2002;16:1129-31.
19. Abassi ZA, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H et al. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume over-load-induced congestive heart failure. Circ Heart Fail 2011;4:463-73.
20. Ertracht O, Liani E, Bachner-Hinenzon N, Bar-Am O, Frolov L, Ovcharenko E et al. The cardioprotective efficacy of TVP1022 in a rat model of ischae-mia/reperfusion. Br J Pharm 2011;163:755-69.
21. Umahara T, Uchihara T, Koyama S, Hashimoto T, Akimoto J, Haraoka J et al. Local extension of HMGB1 in atherosclerotic lesions of human main cerebral and carotid arteries. Histol Histopathol 2014;29:235-42.
22. Liu D, He Z, Wu L, Fang Y. Effects of induction/inhibition of endogenous heme oxygenase-1 on lipid metabolism, endothelial function, and atherosclerosis in rabbits on a high fat diet. J Pharmacol Sci 2012;118:14-24.
23. Kim YS, Kang WS, Kwon JS, Hong MH, Jeong H-Y, Jeong HC et al. Protective role of 5-azacytidine on myocardial infarction is associated with modulation of macrophage phenotype and inhibition of fibrosis. J Cell Mol Med 2014;20:1-10.
24. Chaaya R, Alfarano C, Guilbeau-Frugier C, Coatrieux C, Kesteman AS, Parini A et al. Pargyline reduces renal damage associated with ischaemia-reperfusion and cyclosporin. Nephrol Dial Transplant 2011;26: 489-98.
25. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D et al. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 2010;106:193-202.